Immunocore Holdings plc (IMCR)

New Form 8-K - Immunocore Holdings plc Filed: 2025-08-07 AccNo: 0001140361-25-029350 Size: 482 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Cabaletta Bio Inc (CABA)

New Form 8-K - Cabaletta Bio, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104570 Size: 323 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Achieve Life Sciences Inc. (ACHV)

New Form 8-K - ACHIEVE LIFE SCIENCES, INC. Filed: 2025-08-07 AccNo: 0000950170-25-104569 Size: 533 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Silence Therapeutics Plc (SLN)

New Form 8-K - Silence Therapeutics plc Filed: 2025-08-07 AccNo: 0001193125-25-174958 Size: 265 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

US Physicalrapy (USPH)

New Form 8-K - U S PHYSICAL THERAPY INC /NV Filed: 2025-08-07 AccNo: 0000885978-25-000041 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Collegium Pharmaceutical Inc (COLL)

New Form 8-K - COLLEGIUM PHARMACEUTICAL, INC Filed: 2025-08-07 AccNo: 0001558370-25-010647 Size: 4 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits